Embecta (Nasdaq:EMBC) today revealed its phased plan to create value and shift priorities toward broader medical applications ...

Integration of Abbott’s glucose-ketone sensor with the twiist™ AID System aims to enhance early identification of rising ketones to detect the risk of diabetic ketoacidosis (DKA)1 MANCHESTER, N.H., ...

Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Tandem Diabetes Care, Inc. TNDM is driving transformative innovation to help reduce the burden and create new possibilities for people living with diabetes. Its strong focus on overseas expansion is ...

While some analysts questioned why Medtronic would leave a fast-growing market, others backed the company’s plan to focus on ...

The medical device giant, which is domiciled in Dublin, Ireland but has its main office in Fridley, Minnesota, confirmed that ...

Medtronic has unveiled plans to spin off its diabetes unit into its own publicly traded company that would be headquartered ...

Medical device maker Medtronic said on Wednesday it plans to separate its diabetes business, which houses its insulin pumps ...

Medtronic plans to separate from its diabetes business and launch it as an independent company—one that will count more than ...

CEO Geoff Martha told investors the split simplifies Medtronic’s portfolio, while creating a stand-alone diabetes tech ...

Medtronic bumped up its dividend payout and unveiled plans to spin off its diabetes business as the medical-device company targeted revenue growth for the new fiscal year of roughly 5%.

Senseonics recently introduced a 365-day Continuous Glucose Monitoring system. Click here to read why SENS stock is a Strong ...